Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Reposted - may explain the large BID versus ASK
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(171)
•••
Comment by QContinuum1on Oct 07, 2024 3:56pm
46 Views
Post# 36256692

RE:RE:RE:RE:RE:RE:RE:RE:Reposted - may explain the large BID versus ASK

RE:RE:RE:RE:RE:RE:RE:RE:Reposted - may explain the large BID versus ASK
okgonow wrote:


well we dontbproduce Synthetic ingriedients forn drobinol we only supply the real stuff so you have to nre runn the study with the stuff we make the FDA is pretty sticky when it comes to whats in a aproved drug you cant just put th natural stuff in and say its the same .....they will want a full trial done for aproval


It's nonsensical that someone would post such a thing as 'positive' relating to Medipharm in any case.  It's Phase II and miles away from seeing prime time.  Just like the 'Entropy-Master', anyone can post positive things about cannabis in medicine all day long, but none will benefit Medipharm within the timeframes we want it to or within the timeframes of this company continuing as a going-concern.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities